Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$7.77 - $12.27 $2.27 Million - $3.59 Million
-292,346 Reduced 52.1%
268,750 $2.09 Million
Q2 2023

Aug 14, 2023

BUY
$8.96 - $11.69 $5.03 Million - $6.56 Million
561,096 New
561,096 $5.43 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.14B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Tig Advisors, LLC Portfolio

Follow Tig Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tig Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tig Advisors, LLC with notifications on news.